AmideBio has applied for and been granted patents surrounding both the core technology as well as specific therapeutic peptides discovered through leveraging this core technology. The company continues to pursue patent protection in the U.S. and overseas for a variety of subject matter and the following is a list of published U.S. patents and U.S. patent applications held by the company:

U.S. Granted Patent No. 8,796,431. Efficient Production of Peptides

The present invention relates to processes for the production of peptides, and the peptides produced accordingly. Peptides produced according to the invention may be produced more efficiently than peptides produced according to prior art processes. The production process of the invention may lead to advantages in yield, purity, and/or price. Methods of marketing peptides are also disclosed

U.S. Granted Patent No. 9,163,073. Chemically and thermodynamically stable insulin analogues and improved methods for their production

The subject matter of this invention is directed towards chemically and thermodynamically stable single-chain insulin (SCI) analogues that are resistant to deamidation and fibrillation. The invention further discloses improved methods for the recombinant expression, purification and refolding of SCI.

U.S. Patent Application No. 20140058790. Deuterated peptides

Methods and compositions described herein relate to processes for the production of deuterated peptides, and the deuterated peptides produced accordingly. Deuterated peptides produced according to methods and compositions described herein may be produced more efficiently than such peptides produced according to prior art processes. The production process of according to methods and compositions described herein may lead to advantages in yield, purity, and/or price for deuterated peptides. Methods of marketing deuterated peptides are also disclosed.